跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 38 条关于
“JSKN027”
全部
38
临床试验
22
药物
2
机构
0
资讯
14
7个月前
Alphamab Advances First PD-L1 x VEGFR2 Antibody-Drug Conjugate JSKN027 Into Clinical Trials
9个月前
Alphamab Oncology Receives IND Approval for First-in-Class PD-L1/VEGFR2 Bispecific ADC JSKN027
去年
Alphamab Oncology Advances JSKN003 and JSKN033 in Clinical Trials for Multiple Cancers
去年
Alphamab Oncology Retracts Announcement on JSKN033 Clinical Trial Inclusion
去年
Alphamab Oncology Receives IND Approval for First-in-Class Bispecific ADC JSKN022 Targeting PD-L1 and Integrin αvβ6
去年
Alphamab Oncology's JSKN033 Shows Promise in HER2-Expressing Solid Tumors
去年
Alphamab Oncology's JSKN033 Receives Priority Review for Advanced Malignant Tumors
10个月前
Alphamab Oncology's JSKN003 Receives FDA Fast Track Designation for Platinum-Resistant Ovarian Cancer
去年
Alphamab Oncology's HER2-Targeting ADC JSKN003 Receives FDA Orphan Drug Designation for Gastric Cancer
11个月前
CSPC Pharma's JSKN003 Receives Second Breakthrough Therapy Designation in China for HER2-Positive Colorectal Cancer
第 1 页,共 2 页
上一页
下一页